查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513980

全球生物技術設備市場

Biotechnology Instrumentation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 246 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到2030年，全球生物技術設備市場預計將達到749億美元

2023年全球生物技術設備市場預計為514億美元，預計到2030年將達到749億美元，2023年至2030年複合年成長率為5.5%。免疫檢測系統是本報告分析的細分市場之一，預計複合年成長率為 4.5%，到分析期結束時將達到 261 億美元。分析期間，DNA定序系統領域的複合年成長率預計為 7.8%。

美國市場預計137億美元，中國預計複合年成長率5.2%

2023年美國生技設備市場預計將達137億美元。中國作為世界第二大經濟體，預計2030年市場規模將達119億美元，2023-2030年分析期間複合年成長率為5.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.8% 和 4.7%。在歐洲，德國的複合年成長率預計為 4.3%。

全球生物技術設備市場—主要趨勢與促進因素總結

生物技術產業處於科學進步的最前沿，正在應對從疾病治療到永續農業的全球挑戰，推動了對先進生物技術設備的需求。在研發投資的推動下，該領域的進步正在徹底改變遺傳、蛋白質和細胞分析，對醫療保健、農業和環境科學產生深遠影響。主要市場促進因素包括基因組學和蛋白​​質組學的進步、監管合規性以及生物製藥的擴張。

隨著產業的發展，生物技術設備將繼續推動醫療診斷和環境生物技術的創新，呈現自動化、小型化、與人工智慧技術融合等趨勢。基因組學和蛋白​​質組學的進步將需要次世代定序儀、質譜儀和層析法系統，而監管標準將增加對精密儀器的需求。生物製藥的成長推動了對生物製造設備的需求，技術整合提高了效率和決策流程。

未來，人工智慧整合和永續性實踐將再形成生物技術設備，支援高通量篩檢，並擴大就地檢驗能力。小型化可以靈活使用，人工智慧和機器學習提高了資料分析的準確性。生物技術設備不斷發展，以滿足科學研究和醫療保健的多樣化需求，重點是永續性和就地檢驗的擴展。

受訪企業範例（共147家）

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • GE HealthCare（UK）
  • Gilson Inc.
  • Harvard Bioscience Inc.
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Lonza Group AG
  • PerkinElmer Inc.
  • Roche Diagnostics
  • Shimadzu Corp.
  • Siemens Healthineers
  • Thermo Fischer Scientific Inc.
  • Waters Corp.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP-3504

Global Biotechnology Instrumentation Market to Reach US$74.9 Billion by 2030

The global market for Biotechnology Instrumentation estimated at US$51.4 Billion in the year 2023, is expected to reach US$74.9 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Immunoassay Systems, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$26.1 Billion by the end of the analysis period. Growth in the DNA Sequencing Systems segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.7 Billion While China is Forecast to Grow at 5.2% CAGR

The Biotechnology Instrumentation market in the U.S. is estimated at US$13.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$11.9 Billion by the year 2030 trailing a CAGR of 5.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Biotechnology Instrumentation Market - Key Trends and Drivers Summarized

The biotechnology industry, at the forefront of scientific advancement, addresses global challenges from disease treatment to sustainable agriculture, spurring demand for sophisticated biotechnology instrumentation. Advancements in this field, driven by investments in R&D, revolutionize genetic, protein, and cellular analyses, impacting healthcare, agriculture, and environmental sciences profoundly. Key market growth drivers include advancements in genomics and proteomics, regulatory compliance, and the expansion of biopharmaceuticals.

As the industry evolves, biotechnology instruments will continue to drive innovation in medical diagnostics and environmental biotechnology, with trends leaning towards automation, miniaturization, and integration with AI technologies. Genomics and proteomics advancements necessitate next-generation sequencing devices, mass spectrometers, and chromatography systems, while regulatory standards drive demand for precise instrumentation. The growth of biopharmaceuticals fuels demand for bio-manufacturing instruments, and technological integration enhances efficiency and decision-making processes.

Looking ahead, AI integration and sustainability practices will reshape biotechnology instrumentation, supporting high-throughput screening and expanding point-of-care testing capabilities. Miniaturization allows for flexible use, while AI and machine learning improve data analysis accuracy. With a focus on sustainability and the expansion of point-of-care testing, biotechnology instrumentation continues to evolve, meeting the diverse needs of scientific research and healthcare.

Select Competitors (Total 147 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • GE HealthCare (UK)
  • Gilson Inc.
  • Harvard Bioscience Inc.
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Lonza Group AG
  • PerkinElmer Inc.
  • Roche Diagnostics
  • Shimadzu Corp.
  • Siemens Healthineers
  • Thermo Fischer Scientific Inc.
  • Waters Corp.)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Biotechnology Instrumentation - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Genomic Sequencing Technologies Propel Market Growth
    • Rising Demand for Personalized Medicine Strengthens Business Case for Biotechnology Instruments
    • Growing Application of CRISPR Technology Generates Demand for Advanced Instrumentation
    • Development of Portable and Miniaturized Instruments Accelerates Market Expansion
    • Integration of Artificial Intelligence in Biotechnology Instrumentation Enhances Efficiency
    • Innovations in Proteomics and Metabolomics Throw the Spotlight on Specialized Instruments
    • Expansion of Pharmaceutical and Biopharmaceutical Industries Spurs Market Growth
    • Focus on Drug Discovery and Development Sustains Growth in Biotechnology Instrumentation Market
    • Rising Incidence of Chronic Diseases Generates Demand for Diagnostic Instruments
    • Emphasis on High-Throughput Screening Expands Addressable Market Opportunity
    • Growth in Synthetic Biology Spurs Demand for Custom Instruments
    • Adoption of Cloud-Based Solutions Drives Adoption of Digital Biotechnology Instruments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biotechnology Instrumentation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biotechnology Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Biotechnology Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for DNA Sequencing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for DNA Sequencing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for DNA Sequencing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for MicroArrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for MicroArrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for MicroArrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Liquid Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Liquid Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Liquid Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Laboratory Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Laboratory Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Laboratory Automation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Electrophoresis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Electrophoresis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Electrophoresis Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Product Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • JAPAN
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • CHINA
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • EUROPE
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Biotechnology Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Biotechnology Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • FRANCE
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 47: France Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: France Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: France 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • GERMANY
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Germany Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Germany 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 53: Italy Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Italy Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Italy 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: UK 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 59: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Rest of Europe Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Rest of Europe 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Asia-Pacific 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 65: Rest of World Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of World Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of World 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030

IV. COMPETITION